|
|
| Balance Sheet |
|
| Hester Biosciences Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Bhupendra V Gandhi | | Home : Indian Private | Book Value: 351.3466653 | | BSE Code : 524669 | Market Cap: 1437.49 | | NSE Code : HESTERBIO | P / E : 55.31 | |
| |
|
|
|
| (Rs in Cr.) |
 |
 |
| SOURCES OF FUNDS: | | | Share Capital | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | | Reserves & Surplus | 283.88 | 259.93 | 229.07 | 194.57 | 170.93 | | Total Shareholders Funds | 292.39 | 268.44 | 237.58 | 203.08 | 179.44 | | Secured Loans | 164.32 | 121.91 | 15.90 | 47.90 | 28.29 | | Unsecured Loans | 26.42 | 1.63 | 0.30 | 0.15 | 10.05 | | Total Debt | 190.74 | 123.54 | 16.20 | 48.05 | 38.34 | | Total Liabilities | 483.13 | 391.98 | 253.78 | 251.13 | 217.78 | | APPLICATION OF FUNDS: | | Gross Block | 199.00 | 171.17 | 164.59 | 166.32 | 161.48 | | Less: Accum. Depreciation | 90.78 | 86.86 | 77.95 | 69.85 | 60.88 | | Net Block | 108.22 | 84.31 | 86.64 | 96.47 | 100.60 | | Capital Work in Progress | 148.61 | 81.91 | 3.72 | 0.87 | 0.42 | | Investments | 64.69 | 64.69 | 43.89 | 40.67 | 28.22 | | Inventories | 79.22 | 70.73 | 57.01 | 60.43 | 48.50 | | Sundry Debtors | 82.36 | 56.92 | 45.55 | 44.76 | 32.67 | | Cash and Bank Balance | 5.96 | 1.98 | 1.24 | 5.19 | 2.49 | | Loans and Advances | 57.48 | 64.37 | 44.28 | 28.79 | 27.35 | | Current Liabilities | 59.58 | 31.75 | 24.74 | 25.62 | 22.20 | | Provisions | 3.83 | 1.18 | 3.81 | 0.44 | 0.26 | | Net Current Assets | 161.61 | 161.07 | 119.53 | 113.11 | 88.55 | | Miscellaneous Expenses not w/o | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Total Assets | 483.13 | 391.98 | 253.78 | 251.12 | 217.79 | | Contingent Liabilities | 115.24 | 106.45 | 103.05 | 208.44 | 27.78 |
|
|
|
|
|